These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 9032106

  • 1. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 2. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.
    Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
    [Abstract] [Full Text] [Related]

  • 3. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
    Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH.
    Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
    [Abstract] [Full Text] [Related]

  • 4. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.
    Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J.
    Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696
    [Abstract] [Full Text] [Related]

  • 5. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.
    Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610
    [Abstract] [Full Text] [Related]

  • 6. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [Abstract] [Full Text] [Related]

  • 7. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K, Christensen PK, Jensen BR, Parving HH.
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [Abstract] [Full Text] [Related]

  • 8. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 10. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
    Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.
    Diabetologia; 2009 Jan; 52(1):46-9. PubMed ID: 18974967
    [Abstract] [Full Text] [Related]

  • 11. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH.
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [Abstract] [Full Text] [Related]

  • 12. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [Abstract] [Full Text] [Related]

  • 13. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al.
    Cooper ME.
    Diabetes Care; 2000 Dec; 23(12):1723-4. PubMed ID: 11128340
    [No Abstract] [Full Text] [Related]

  • 14. Optimal dose of losartan for renoprotection in diabetic nephropathy.
    Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH.
    Nephrol Dial Transplant; 2002 Aug; 17(8):1413-8. PubMed ID: 12147788
    [Abstract] [Full Text] [Related]

  • 15. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 16. Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
    Rossing K, Jacobsen P, Pietraszek L, Parving HH.
    Diabetes Care; 2003 Aug 25; 26(8):2268-74. PubMed ID: 12882847
    [Abstract] [Full Text] [Related]

  • 17. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH.
    J Diabetes Complications; 1996 Aug 25; 10(3):133-5. PubMed ID: 8807457
    [Abstract] [Full Text] [Related]

  • 18. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH, Hommel E, Jensen BR, Hansen HP.
    Kidney Int; 2001 Jul 25; 60(1):228-34. PubMed ID: 11422755
    [Abstract] [Full Text] [Related]

  • 19. Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients.
    Christensen PK, Lund S, Parving HH.
    Kidney Int; 2001 Oct 25; 60(4):1435-42. PubMed ID: 11576357
    [Abstract] [Full Text] [Related]

  • 20. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
    Ruddy TD, Fodor JG.
    Cardiovasc Drugs Ther; 1997 Sep 25; 11(4):581-90. PubMed ID: 9358963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.